Cargando…

Primary tumor volume and prognosis for patients with p16-positive and p16-negative oropharyngeal squamous cell carcinoma treated with radiation therapy

BACKGROUND: The prescribed radiation dose to patients with oropharyngeal squamous cell carcinoma (OPSCC) is standardized, even if the prognosis for individual patients may differ. Easy-at-hand pre-treatment risk stratification methods are valuable to individualize therapy. In the current study we as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Adrian, Gabriel, Carlsson, Henrik, Kjellén, Elisabeth, Sjövall, Johanna, Zackrisson, Björn, Nilsson, Per, Gebre-Medhin, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9195357/ https://www.ncbi.nlm.nih.gov/pubmed/35701827 http://dx.doi.org/10.1186/s13014-022-02074-7

Ejemplares similares

Weight and body mass index in relation to irradiated volume and to overall survival in patients with oropharyngeal cancer: a retrospective cohort study
por: Ottosson, Sandra, et al.
Publicado: (2014)

Regional recurrence of oropharyngeal cancer after definitive radiotherapy: a case control study
por: Söderström, Karin, et al.
Publicado: (2015)

Treatment failure patterns are similar between p16− and p16+ oropharyngeal squamous cell carcinomas
por: Hamill, Chelsea S., et al.
Publicado: (2022)

Induction Chemotherapy for p16 Positive Oropharyngeal Squamous Cell Carcinoma
por: Saito, Yuki, et al.
Publicado: (2016)

Evaluation of p16 expression in oral and oropharyngeal squamous cell carcinoma
por: Saxena, Pallavi, et al.
Publicado: (2022)

Genomic Copy Number Variations Characterize the Prognosis of Both P16-Positive and P16-Negative Oropharyngeal Squamous Cell Carcinoma After Curative Resection
por: Rhie, Arang, et al.
Publicado: (2015)

Human Papillomavirus Detection in Oropharyngeal Squamous Cell Carcinoma Using p16 Immunohistochemistry
por: Sabu, Annetmary, et al.
Publicado: (2019)

Correlation of p16 immunohistochemistry with clinical and epidemiological features in oropharyngeal squamous-cell carcinoma
por: de C. Ferreira, Chrystiano, et al.
Publicado: (2021)

Weight loss in patients with head and neck cancer during and after conventional and accelerated radiotherapy
por: Ottosson, Sandra, et al.
Publicado: (2013)

Human papillomavirus DNA and p16 expression in Japanese patients with oropharyngeal squamous cell carcinoma
por: Kawakami, Hisato, et al.
Publicado: (2013)

Correlation of PET-CT nodal SUVmax with p16 positivity in oropharyngeal squamous cell carcinoma
por: Clark, Jessica, et al.
Publicado: (2015)

Synchronous p16(+) nasopharyngeal and oropharyngeal squamous cell carcinoma: a case report and review
por: Ali, Muhammad, et al.
Publicado: (2021)

Increased PD-L1 and p16 expression are common in oropharyngeal squamous cell carcinoma
por: Shestakova, Anna, et al.
Publicado: (2021)

Correlation of immune makers with HPV 16 infections and the prognosis in oropharyngeal squamous cell carcinoma
por: Zhu, Yingying, et al.
Publicado: (2023)

Differences in clinical and imaging characteristics between p16-positive non-smokers and p16-positive smokers or p16-negative patients in oropharyngeal carcinoma
por: Trinh, Jean-Michel, et al.
Publicado: (2021)

Association of p16 as Prognostic Factors for Oropharyngeal Cancer: Evaluation of p16 in 1470 Patients for a 16 Year Study in Northeast China
por: Meng, Hong-xue, et al.
Publicado: (2018)

Prognostic utility of HPV specific testing in addition to p16 immunohistochemistry in oropharyngeal squamous cell carcinoma
por: Sathasivam, H P, et al.
Publicado: (2018)

Potential association of the prognostic index and survival in patients with p16-positive oropharyngeal squamous cell carcinoma
por: Brkic, Faris F., et al.
Publicado: (2021)

Margin Sampling and Survival Outcomes in Oral Cavity and p16-Positive Oropharyngeal Squamous Cell Carcinoma
por: MacKay, Colin, et al.
Publicado: (2022)

ARTSCAN III: A Randomized Phase III Study Comparing Chemoradiotherapy With Cisplatin Versus Cetuximab in Patients With Locoregionally Advanced Head and Neck Squamous Cell Cancer
por: Gebre-Medhin, Maria, et al.
Publicado: (2021)

Immunohistochemical Evaluation of p16 and p53 in Oral and Oropharyngeal Squamous Cell Carcinoma with Special Regard to Human Papillomavirus Status
por: Ghosh, Urvashi, et al.
Publicado: (2022)

HPV infection and P16 expression in oral and oropharyngeal cancer in Kazakhstan
por: Adilbay, Dauren, et al.
Publicado: (2018)

Long-Term Survival and Recurrence in Oropharyngeal Squamous Cell Carcinoma in Relation to Subsites, HPV, and p16-Status
por: Wendt, Malin, et al.
Publicado: (2021)

Correction to: Potential association of the prognostic index and survival in patients with p16-positive oropharyngeal squamous cell carcinoma
por: Brkic, Faris F., et al.
Publicado: (2021)

Prediction of Occult Contralateral Nodal Metastasis in Surgical Treated p16 Negative Oropharyngeal Squamous Cell Carcinoma
por: Huang, Hui-Shan, et al.
Publicado: (2022)

Erythropoietin suppresses the activation of pro-apoptotic genes in head and neck squamous cell carcinoma xenografts exposed to surgical trauma
por: Lindgren, Gustaf, et al.
Publicado: (2014)

Prognostic impact of additional HPV diagnostics in 102 patients with p16-stratified advanced oropharyngeal squamous cell carcinoma
por: Weiss, Bernhard G., et al.
Publicado: (2020)

Evaluating of HPV–DNA ISH as an adjunct to p16 testing in oropharyngeal cancer
por: Chi, Jeffrey, et al.
Publicado: (2020)

Prognostic Value of Pathologically Positive Nodal Number in p16-Negative Oropharyngeal and Hypopharyngeal Squamous Cell Carcinoma with pN3b Status
por: Tsai, Ming-Hsien, et al.
Publicado: (2022)

Trends in Swallowing Outcomes Following Deintensified Treatment in Selected p16+ Oropharyngeal Carcinoma
por: Lee, Esther, et al.
Publicado: (2023)

Association of Combined p73 and p53 Genetic Variants with Tumor HPV16-Positive Oropharyngeal Cancer
por: Wang, Zhongqiu, et al.
Publicado: (2012)

Human papillomavirus-16 infection and p16 expression in oral squamous cell carcinoma
por: Tokuzen, Norihiko, et al.
Publicado: (2021)

p16(INK4A) and p14(ARF) Gene Promoter Hypermethylation as Prognostic Biomarker in Oral and Oropharyngeal Squamous Cell Carcinoma: A Review
por: Al-Kaabi, A., et al.
Publicado: (2014)

Prognostic impact of p16 and PD-L1 expression in patients with oropharyngeal squamous cell carcinoma receiving a definitive treatment
por: Sato, Fumihiko, et al.
Publicado: (2019)

Distinct Outcomes of Oropharyngeal Squamous Cell Carcinoma Patients after Distant Failure According to p16 Status: Implication in Therapeutic Options
por: Modesto, Anouchka, et al.
Publicado: (2021)

Differences in the prognosis of HPV16-positive patients with squamous cell carcinoma of head and neck according to viral load and expression of P16
por: Biesaga, Beata, et al.
Publicado: (2017)

p16 protein expression is associated with a poor prognosis in squamous cell carcinoma of the lung
por: Huang, C-I, et al.
Publicado: (2000)

Correlation between human papillomavirus and p16 overexpression in oropharyngeal tumours: a systematic review
por: Grønhøj Larsen, C, et al.
Publicado: (2014)

Immune Cell Density Evaluation Improves the Prognostic Values of Staging and p16 in Oropharyngeal Cancer
por: Descamps, Géraldine, et al.
Publicado: (2022)

p16, pRb, and p53 in Feline Oral Squamous Cell Carcinoma
por: Supsavhad, Wachiraphan, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_e6a24h9h9aolpc9m73skjg2mmi